Skip to main content
OpenTrials
Completed

NCT Number: NCT01852487

Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia

Androgenic alopecia is the most common cause of hair loss in men. Finasteride and minoxidil are available in treatment of androgenetic alopecia, although the former causes decreased libido or ejaculate volume, erectile dysfunction, the latter causes scaling, itching of the scalp. Recently, Pulpkin Seed Oil shows some improved clinical efficacy on scalp hair growth in men with androgenetic alopecia, but there is no evidence to support this.

The investigators conducted a randomized, double-blind, placebo-controlled efficacy and tolerability trial of Pumpkin seed oil (400mg/day)therapy in male patients with androgenetic alopecia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Androgenic Alopecia Alopecia Congenital, Hereditary, and Neonatal Diseases and Abnormalities Endocrine Gland Neoplasms Endocrine System Diseases Genetic Diseases, Inborn Hair Diseases Hypotrichosis Multiple Endocrine Neoplasia Multiple Endocrine Neoplasia Type 1 Neoplasms Neoplasms by Site Neoplasms, Multiple Primary Neoplastic Syndromes, Hereditary Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–65 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Pusan National University Yangsan Hospital

Yangsan, Gyeongsangnam-do, 626-770, South Korea

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 to 65 years of age
  • Androgenetic alopecia of Norwood-Hamilton scale grade II-V

Exclusion criteria

  • Severe medical problems including renal problems, prostate diseases, diabetes mellitus o
  • Patients who took any medicine which can affect the hair growth in recent 3 months.

Treatment and study plan

400mg /day during 6 months

Dietary Supplement

Primary outcomes

  1. investigator assessment score using photographs of scalp hair

    Time frame: at weeks 12 and 24

Secondary outcomes

  1. patient self-assessment scores

    Time frame: at weeks 12 and 24

Other outcomes

  1. hair analysis using phototrichogram

    Time frame: at weeks 12 and 24

Sponsors and collaborators

Lead sponsor

Dream Plus

Industry

Registry information

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
May 13, 2013
Registry last updated
May 13, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.